Biosurgery Market by Product Type, Origin, Surgery, End-User, & Region for 2024-2031

Biosurgery Market Valuation - 2024-2031

The growing need for minimally invasive surgical techniques, which provide fewer surgical complications, better patient outcomes, quicker recovery times, and less scarring, is the main factor driving the biosurgery market. According to the analyst from Verified Market Research, the biosurgery market is estimated to reach a valuation of USD 25648.82 Million over the forecast subjugating around USD 16335.26 Million valued in 2024.

The aging population and the associated growth in the frequency of chronic diseases are also key drivers of the biosurgery market since these ailments necessitate surgical operations that can be aided by the use of biosurgical products. It enables the market to grow at a CAGR of 6.4% from 2024 to 2031.

Biosurgery Market: Definition/ Overview

Biosurgery is the use of living organisms, specifically sterile maggots, to treat infected wounds and promote healing. This novel technique uses these organisms' natural properties to remove necrotic tissue, reduce bacterial load, and accelerate tissue regeneration. Biosurgery has applications beyond wound care; it is used in a variety of surgical specialties, including orthopedics, plastic surgery, and chronic wound treatment, when traditional approaches may be ineffective.

What are the Factors that Propel the Demand for the Biosurgery Market?

The growing number of chronic diseases requiring surgical procedures is a major driver of the biosurgery market. According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death worldwide, killing an estimated 17.9 million people each year. This high disease load is increasing demand for improved biosurgery products in cardiac and vascular procedures, resulting in market growth.

The worldwide aging population is considerably driving the growth of the biosurgery market. According to the United Nations Department of Economic and Social Affairs, by 2050, one in every six individuals will be over the age of 65 (16%), up from one in every eleven (9%) in 2019. This demographic transition is increasing the amount of age-related surgeries, particularly orthopedic treatments, which drives the demand for biosurgery products.

Furthermore, advances in regenerative medicine and tissue engineering are driving the biosurgery market ahead. According to the National Institutes of Health (NIH), the global regenerative medicine market is predicted to grow to USD 67 Billion by 2020. This expansion is being driven by increased research and development activity in stem cell therapies and tissue engineering, which are closely related to biosurgery applications.

What are the Factors Hinder the Growth of the Biosurgery Market?

The high cost of biosurgery products and procedures is a key commercial barrier for the market. The high cost of biosurgical products, such as hemostatic agents and surgical sealants, limits accessibility, especially in developing countries with limited healthcare resources. Patients without proper insurance coverage find these items prohibitively expensive, resulting in a preference for traditional surgical approaches that impede the development of modern biosurgical techniques and technology.

Furthermore, limited reimbursement policies also present obstacles to the biosurgery market. In many areas, reimbursement for biosurgical devices does not fully cover their high prices, making them less appealing to both healthcare professionals and patients. Low reimbursement rates limit access to these advanced treatments, especially in regions where out-of-pocket costs are high. This expensive hurdle resulted in reliance on traditional surgical treatments, thereby impeding the growth of the biosurgery market.

Category-Wise Acumens

How does the Increasing Adoption of Bone-graft Substitutes Influence Market Growth?

According to VMR analysis, the bone-graft substitute segment is estimated to hold the largest market share during the forecast period. The growing number of orthopedic operations increases the demand for bone-graft alternatives. As the population ages, the prevalence of disorders like osteoporosis and fractures grows, necessitating surgical procedures. Bone-graft substitutes provide effective options for bone repair and regeneration, making them indispensable in surgical procedures, hence increasing their market share and growth.

Technological developments in bone-graft substitutes improve their efficacy and safety, bolstering their market domination. Synthetic materials and bioactive coatings improve the substitutes' biocompatibility and osteoconductivity, resulting in better patient outcomes. The ongoing development of improved goods customized to specific surgical demands improves their adoption among healthcare professionals, helping to drive the segment's growth.

Furthermore, the growing preference for minimally invasive surgical techniques drives demand for bone-graft replacements. These items allow for faster recovery times and fewer postoperative problems than previous approaches. As healthcare professionals and consumers seek less intrusive solutions, bone-graft substitutes are projected to gain traction in a variety of surgical applications, consolidating their market position.

How Do Neuro & Spine Surgery Propel the Growth of the Biosurgery Market?

The neuro and spine surgery segment is estimated to dominate the biosurgery market during the forecast period. The growing prevalence of neurological illnesses contributes considerably to the dominance of neuro and spine surgery. Spinal injuries, tumors, and degenerative disorders are becoming more common, demanding complex surgical procedures. As the demand for effective treatment alternatives increases, so does the dependence on biosurgical products to improve surgical results and reduce complications, driving market expansion in this segment.

Technological improvements in surgical procedures and biosurgical devices contribute to the brain and spine surgery segment's dominance. Minimally invasive methods, bioactive materials, and enhanced imaging technology have all contributed to increased surgical precision and patient safety. These developments not only improve the effectiveness of neurosurgical treatments but also contribute to faster recovery times, making biosurgical alternatives more appealing to both healthcare professionals and patients.

Furthermore, the increasing emphasis on customized medicine in neurosurgery has a significant impact on the segment's market share. Tailored therapy options that take into account specific patient demands and situations are growing popular. This trend stimulates the development and use of biosurgical products that may be tailored to specific surgical applications, bolstering the brain and spine surgery segment's dominant position in the biosurgery market.

Country/Region-wise Acumens

How Does the High Prevalence of Chronic Diseases Influence the Growth of the Market in North America?

According to VMR analyst, North America is estimated to dominate the biosurgery market during the forecast period. North America has a high prevalence of chronic disorders that necessitate surgical procedures, which drives the biosurgery market. According to the Centers for Disease Control and Prevention (CDC), by 2020, 6 in 10 adults in the United States have a chronic condition, with 4 in 10 having two or more. Heart disease is the main cause of death for around 30.3 million adults in the United States. This high illness prevalence leads to a growing number of surgeries that use biosurgery products.

North America's well-established healthcare system and high healthcare spending contribute greatly to the region's biosurgery market domination. According to the Centers for Medicare and Medicaid Services (CMS), healthcare spending in the United States increased by 9.7% in 2020 to $4.1 trillion, or $12,530 per person. The level of healthcare expenditure allows for greater adoption of advanced biosurgery products and technologies.

Furthermore, the expanding elderly population in North America is a significant driver of the biosurgery market. According to the United States Census Bureau, the number of Americans aged 65 and up is expected to nearly double, from 52 million in 2018 to 95 million by 2060. This demographic transition is resulting in a rise in age-related surgeries, notably orthopedic ones. According to the American Academy of Orthopedic Surgeons, the number of total knee replacements in the United States is predicted to increase by 673% to 3.48 million per year by 2030, creating demand for biosurgery products in orthopedic applications.

How Does the Rising Healthcare Expenditure Drive the Market in the Asia Pacific Region?

The Asia Pacific region is estimated to exhibit the highest growth within the biosurgery market during the forecast period. The Asia Pacific region's increased healthcare spending is driving the adoption of innovative medical technology, such as biosurgery products. The World Health Organization (WHO) states that healthcare expenditure in the Western Pacific Region, which encompasses much of Asia, increased at an average annual rate of 6.6% between 2000 and 2017. This significant increase in healthcare investment is fueling the expansion of surgical facilities and the application of new biosurgery techniques.

Furthermore, the Asia Pacific region is experiencing an increase in cardiovascular disorders, which necessitates more cardiac procedures and drives demand for biosurgery products. According to the Asian Pacific Society of Cardiology, cardiovascular disease causes 35% of all fatalities in the Asia Pacific region, which is higher than the global rate of 31%. This increasing disease burden is propelling the growth of the biosurgery market, particularly for products used in cardiac and vascular surgeries.

Competitive Landscape

The biosurgery market is extremely competitive, with several major firms competing for market share. These companies are aggressively producing novel goods, increasing their product portfolios, and pursuing strategic activities including mergers, acquisitions, and collaborations to boost their market position.

Some of the prominent players operating in the biosurgery market include:

Johnson & Johnson

Baxter International, Inc.

Medtronic Plc

Becton, Dickinson and Company (BD)

Braun Melsungen AG

Stryker Corporation

CSL Ltd.

Hemostasis LLC

Integra Lifesciences Holdings Corp.

Latest Developments

In March 2023, Researchers from Terasaki Institute for Biomedical Innovation (TIBI) developed an injectable biomaterial with higher adhesive strength, stretchability, and toughness. Gelatin hydrogels are ideal for surgical wound sealants due to their rapid gel time and tunable adhesion levels.

Biosurgery Market, By Category

• Product Type:
• Bone-graft Substitutes
• Soft-tissue Attachments
• Hemostatic Agents
• Surgical Sealants and Adhesives
• Adhesion Barriers
• Staple-line Reinforcement Agents
• Origin:
• Biological
• Synthetic
• Surgery:
• Orthopedic
• General
• Neuro and Spine
• Cardiovascular
• Reconstructive
• Gynecological
• Urological
• Thoracic
• End-User:
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa
• Analyst's Take
• The Biosurgery Market is poised for substantial growth owing to increasing surgical procedures, rising geriatric population, and the growing prevalence of chronic diseases. Technological advancements in biomaterials and surgical techniques are further propelling market expansion. Additionally, the rising adoption of minimally invasive surgeries and the growing awareness regarding the benefits of biosurgery products among healthcare professionals and patients are expected to drive market demand in the forecast period